Immunogenicity of constitutively active V599EBRaf.
Andersen MH, Fensterle J, Ugurel S, Reker S, Houben R, Guldberg P, Berger TG, Schadendorf D, Trefzer U, Bröcker EB, Straten P, Rapp UR, Becker JC.
Cancer Res. 2004 Aug 1;64(15):5456-60.PMID: 15289355 [PubMed - indexed for MEDLINE]Related articlesFree article